ReviewAnalytical and bioanalytical chemistry2026
The development and use of isotope dilution mass spectrometry methods for the quantification of target proteins in certified reference materials.
Review in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
14 authors.
Funding
Abstract
Originally developed for small molecules in the late 1970s and early 1980s, isotope dilution mass spectrometry (IDMS) also has become the "go to" method of quantification for those wishing to characterize the mass fraction or amount of substance content of proteins in matrix-based certified reference materials (CRMs). While instrumental factors can impact the accuracy of IDMS methods, the use of double IDMS, higher order approaches, and "exact matching" have done a lot to improve the accuracy of the results. This review shows the development of IDMS for the quantification of proteins from being a method only used for value assignment of primary calibrators using isotope-labelled peptides as internal standards to a method for quantification of proteins in complex biological matrices such as serum and blood using isotope-labelled recombinant intact proteins as internal standards. It will discuss the challenges and limitations of currently used organic IDMS peptide-based approaches regarding the definition of the measurands, equilibration of sample and internal standard, digestion efficiency, and stability and suitability of the internal standards. This paper reviews the steps taken to assess the accuracy of the peptide- and protein-based IDMS methods used for the characterization of CRMs and the requirement to ensure comparability in laboratory diagnostics down to the patient level. Furthermore, it will give an outlook on future challenges, such as including structural and protein activity information in the results.
Indexed as
Identifiers
42525266What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.